Pfizer Q3 2025 slides: EPS beats expectations as company raises guidance
PositiveFinancial Markets

Pfizer has reported its Q3 2025 earnings, surpassing expectations with a notable increase in earnings per share. This positive performance has led the company to raise its financial guidance for the upcoming quarters, indicating strong confidence in its future prospects. Such results are significant as they reflect Pfizer's resilience and adaptability in a competitive market, potentially boosting investor confidence and impacting stock performance.
— Curated by the World Pulse Now AI Editorial System












